209 related articles for article (PubMed ID: 30142565)
1. Analytical methods for the study of bioactive compounds from medicinally used Echinacea species.
Bruni R; Brighenti V; Caesar LK; Bertelli D; Cech NB; Pellati F
J Pharm Biomed Anal; 2018 Oct; 160():443-477. PubMed ID: 30142565
[TBL] [Abstract][Full Text] [Related]
2. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Gibbons S; Phillipson JD
J Pharm Pharmacol; 2005 Aug; 57(8):929-54. PubMed ID: 16102249
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different green-extraction techniques and determination of the phytochemical profile and antioxidant activity of Echinacea angustifolia L. extracts.
Russo D; Faraone I; Labanca F; Sinisgalli C; Bartolo M; Andrade PB; Valentao P; Milella L
Phytochem Anal; 2019 Sep; 30(5):547-555. PubMed ID: 31148295
[TBL] [Abstract][Full Text] [Related]
4. A new method based on supercritical fluid extraction for polyacetylenes and polyenes from Echinacea pallida (Nutt.) Nutt. roots.
Tacchini M; Spagnoletti A; Brighenti V; Prencipe FP; Benvenuti S; Sacchetti G; Pellati F
J Pharm Biomed Anal; 2017 Nov; 146():1-6. PubMed ID: 28841426
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous metabolite fingerprinting of hydrophilic and lipophilic compounds in Echinacea pallida by high-performance liquid chromatography with diode array and electrospray ionization-mass spectrometry detection.
Pellati F; Orlandini G; Benvenuti S
J Chromatogr A; 2012 Jun; 1242():43-58. PubMed ID: 22560343
[TBL] [Abstract][Full Text] [Related]
6. Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS.
Spelman K; Wetschler MH; Cech NB
J Pharm Biomed Anal; 2009 Jul; 49(5):1141-9. PubMed ID: 19321283
[TBL] [Abstract][Full Text] [Related]
7. Studies on phytochemical, antioxidant, anti-inflammatory, hypoglycaemic and antiproliferative activities of Echinacea purpurea and Echinacea angustifolia extracts.
Aarland RC; Bañuelos-Hernández AE; Fragoso-Serrano M; Sierra-Palacios ED; Díaz de León-Sánchez F; Pérez-Flores LJ; Rivera-Cabrera F; Mendoza-Espinoza JA
Pharm Biol; 2017 Dec; 55(1):649-656. PubMed ID: 27951745
[TBL] [Abstract][Full Text] [Related]
8. Effects of chemically characterized fractions from aerial parts of Echinacea purpurea and E. angustifolia on myelopoiesis in rats.
Ramasahayam S; Baraka HN; Abdel Bar FM; Abuasal BS; Widrlechner MP; Sayed KA; Meyer SA
Planta Med; 2011 Nov; 77(17):1883-9. PubMed ID: 21870322
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous analysis of alkamides and caffeic acid derivatives for the identification of Echinacea purpurea, Echinacea angustifolia, Echinacea pallida and Parthenium integrifolium roots.
Laasonen M; Wennberg T; Harmia-Pulkkinen T; Vuorela H
Planta Med; 2002 Jun; 68(6):572-4. PubMed ID: 12094312
[TBL] [Abstract][Full Text] [Related]
10. Variability in the composition of anti-oxidant compounds in Echinacea species by HPLC.
Pellati F; Benvenuti S; Melegari M; Lasseigne T
Phytochem Anal; 2005; 16(2):77-85. PubMed ID: 15881113
[TBL] [Abstract][Full Text] [Related]
11. Chromatographic methods for metabolite profiling of virus- and phytoplasma-infected plants of Echinacea purpurea.
Pellati F; Epifano F; Contaldo N; Orlandini G; Cavicchi L; Genovese S; Bertelli D; Benvenuti S; Curini M; Bertaccini A; Bellardi MG
J Agric Food Chem; 2011 Oct; 59(19):10425-34. PubMed ID: 21830789
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4).
Modarai M; Yang M; Suter A; Kortenkamp A; Heinrich M
Planta Med; 2010 Mar; 76(4):378-85. PubMed ID: 19790031
[TBL] [Abstract][Full Text] [Related]
13.
Burlou-Nagy C; Bănică F; Jurca T; Vicaș LG; Marian E; Muresan ME; Bácskay I; Kiss R; Fehér P; Pallag A
Plants (Basel); 2022 May; 11(9):. PubMed ID: 35567246
[No Abstract] [Full Text] [Related]
14. [History of a plant: the example of Echinacea].
Hostettmann K
Forsch Komplementarmed Klass Naturheilkd; 2003 Apr; 10 Suppl 1():9-12. PubMed ID: 12808356
[TBL] [Abstract][Full Text] [Related]
15. Use of quantitative flow cytometry to measure ex vivo immunostimulant activity of echinacea: the case for polysaccharides.
Pillai S; Pillai C; Mitscher LA; Cooper R
J Altern Complement Med; 2007; 13(6):625-34. PubMed ID: 17718645
[TBL] [Abstract][Full Text] [Related]
16. Biotechnological production of caffeic acid derivatives from cell and organ cultures of Echinacea species.
Murthy HN; Kim YS; Park SY; Paek KY
Appl Microbiol Biotechnol; 2014 Sep; 98(18):7707-17. PubMed ID: 25077780
[TBL] [Abstract][Full Text] [Related]
17. Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants.
Hou CC; Chen CH; Yang NS; Chen YP; Lo CP; Wang SY; Tien YJ; Tsai PW; Shyur LF
J Nutr Biochem; 2010 Nov; 21(11):1045-59. PubMed ID: 20005088
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid derivatives production by hairy root cultures of Echinacea purpurea.
Liu CZ; Abbasi BH; Gao M; Murch SJ; Saxena PK
J Agric Food Chem; 2006 Nov; 54(22):8456-60. PubMed ID: 17061821
[TBL] [Abstract][Full Text] [Related]
19. Re-opening the stage for Echinacea research - Characterization of phylloxanthobilins as a novel anti-oxidative compound class in Echinacea purpurea.
Karg CA; Wang P; Vollmar AM; Moser S
Phytomedicine; 2019 Jul; 60():152969. PubMed ID: 31153733
[TBL] [Abstract][Full Text] [Related]
20. Echinacea standardization: analytical methods for phenolic compounds and typical levels in medicinal species.
Perry NB; Burgess EJ; Glennie VL
J Agric Food Chem; 2001 Apr; 49(4):1702-6. PubMed ID: 11308313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
